Germany's telecoms regulator says Huawei can stay in the 5G network race, the European Central Bank faces stimulus pressure over a falling inflation outlook and the FT reports that Purdue Pharma, the makers of Oxycontin, tried to buy Reckitt Benckiser's addiction treatment business. Plus, the FT's Camilla Hodgson sets up the $30bn legal battle between Apple and Qualcomm that will play out in a San Diego court on Monday.
","author_name":"Financial Times"}